Nuvectra Corp. (fka NVTRQ)

[Citrati]

outlaw, I think this is a prime example of the confluence of 3 things.

1. Volatility of a low float stock.
2. Profit taking in an early stage bio as focus turns to financial results and growth.
3. Shorters jumping on based on 1 and 2.
Then add traders plus internet euphoria then fear and this is becoming the common scenario for early stage bio tech stocks.
Just the way this world is now.

Pretty tough to think that anything here or lower won't make some nice green lettuce when 4Q #'s are released. If you know any of the sales reps it would be interesting for their take on the difference between sales acceleration this Q and last Q as well as thoughts on cost of sales differential.

Have to confess, I am somewhat surprised to see it walk through 9.50 this quickly.
Spent almost the entire day basing between 8 and 8.25 which may turn into support.

The #s need to be good for NVTR not to turn into a buy the run-up sell the news stock for a few quarters. Bares watching.

No matter what, it was an awesome reco. Thanks again.